Also, the identification of the BRCA1/2 mutation status can not only inform family members of BRCA1/2 mutation carriers about their potential cancer risks but also help identify those who could benefit from active surveillance or risk reduction strategies, such as risk-reducing surgeries for breasts and ovaries [5,21,22,23]. This evidence concerns the gene BRCA1 and cancer.